Recent Company News press releases & news

Presswire is the leading news platform where businesses, educational institutions, news reporters, etc. come together to share compelling news stories that transform opinions and impact lives. Presswire has an extensive media contact list for press releases, reaching millions of contacts. We ensure that your story lands on the right business desks and the right mass media outlets. To begin your press release distribution, send your stories to Presswire or by filling out the form here.

1

 

[PRESSWIRE] Vancouver, BC - February 14th, 2022 -- Skyharbour Resources Ltd.’s (TSX-V:SYH) (OTCQB:SYHBF) (Frankfurt:SC1P) (the “Company”) partner company Azincourt Energy (“Azincourt), is pleased to provide an update on the 2022 exploration program at the East Preston uranium project, located in the western Athabasca Basin, Saskatchewan, Canada.

 

[PRESSWIRE] VANCOUVER, British Columbia - February 14, 2022 -- Fobi AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (the "Company" or "Fobi"), a leader in providing real-time data analytics through artificial intelligence to drive customer activation and engagement is pleased to announce the release of their new digital identification (‘ID’) solution, AltID, which plugs into the recently released Fobi PassPro enhanced wallet pass platform.  AltID will enable organizations to move from paper and plastic-based analog credential systems to digitally validated credentials for users at businesses, schools, venues, and across regulated industries. 

1

 

[PRESSWIRE] Vancouver, BC, February 10, 2022, UPCO International Inc. (CSE: UPCO) (OTC: UCCPF) (Frankfurt: U06) (“UPCO” or the “Company") is pleased to announce its partnership with Snoop Consulting, a Digital Transformation company that delivers innovative products and strategic advice to digital businesses. This alliance was established to collaborate on improving the user experience of the new UPCO messaging and payments application.

 

[PRESSWIRE] Vancouver, B.C. – February 9, 2022 – FOBI AI Inc. (TSXV: FOBI, OTCQB: FOBIF) (the "Company" or "FOBI"), a leader in providing real-time data analytics through artificial intelligence to drive operational efficiencies and profitability, is pleased to announce that it has launched its latest mobile wallet innovation with “Fan Pass.”  Fobi’s Fan Pass is a new fan engagement platform built off of the recently released PassPro solution, Fobi’s new enterprise-grade SaaS platform. 

1

 

[PRESSWIRE] Vancouver, British Columbia – February 8, 2022 – NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQB:NAUFF) (Frankfurt:5E50) is pleased to announce assays from the first four holes of the drilling program at its Limousine Butte Project, Nevada (the “Project”) located on the southern part of the Carlin Trend. The initial holes are part of the Company’s inaugural 10,000 meter drill program at the Project and further assays from the program are expected shortly. Drill results will continue to be released for the remainder of the first half of 2022.

1

 

[PRESSWIRE] London, UK - 3 February 2022 -- In January 2002, CEO Europe was launched in France with a focus on Interim Management services dedicated to European Startups and Venture Capitalists. Now, twenty years later, CEO Europe has expanded to become CEO Worldwide, and is excited to celebrate twenty years of partnering world-leading executive talent with companies around the globe.

1

 

[PRESSWIRE] TORONTO, Ontario and CAMBRIDGE, Mass. — February 3, 2022 — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today that it has appointed Drs. Guy Rouleau and Alain Dagher to its scientific advisory board (SAB).

 

[PRESSWIRE] Vienna - 03 February, 2022 -- CEBINA GmbH, Central European Biotech Incubator and Accelerator with its partner URSAPHARM Arzneimittel GmbH, today announce new results demonstrating that azelastine, the active drug in Pollival®, URSAPHARM’s widely available anti-allergy nasal spray, is an effective anti-viral against the globally dominant omicron SARS-CoV-2 variant in laboratory conditions.

1

 

[PRESSWIRE] Vancouver, BC - February 3rd, 2022 -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQB: SYHBF) (Frankfurt: SC1P) (the “Company”) is pleased to announce the results of the final six holes from its 2021 summer/fall diamond drilling program at its 100% owned Moore Uranium Project.

 

[PRESSWIRE] VANCOUVER, B.C - February 3, 2022 -- Fobi AI Inc. (FOBI: TSXV FOBIF: OTCQB) (the “Company” or “FOBI”), a leader in providing real-time data analytics through artificial intelligence to drive operational efficiencies and profitability, today announced a strategic partnership with Barnet Technologies Corp.